Skip to content

The development of treatment using the neurofeedback for patients with obsessive-compulsive disorder

The development of treatment using the neurofeedback for patients with obsessive-compulsive disorder - The development of treatment using the neurofeedback for patients with obsessive-compulsive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013123
Enrollment
20
Registered
2014-02-17
Start date
2014-02-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessve-compulsive disorder

Interventions

The prefrontal cortex and the striatum is key brain structure in the pathophysiology of obsessive-compulsive disorder. We are planning to treat patients with obsessive-compulsive disorder through trai

Sponsors

Graduate School of Medical Science, Kyoto Prefectural University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We will recruit the patients with obsessive-compulsive disorder at the Kyoto Prefectural University of Medicine Hospital, Kyoto, Japan. Only patients who give written, informed consent after receiving a description of this study will take part.

Exclusion criteria

Exclusion criteria: The exclusion criteria for patients: 1) cardiac pacemakers or other metallic implants or artifacts; 2) significant disease, including neurological diseases, disorders of the pulmonary, cardiac, renal, hepatic, or endocrine systems, or metabolic disorders; 3) prior psychosurgery; 4) pregnancy.

Design outcomes

Primary

MeasureTime frame
Yale-Brown Obsessive Compulsive Scale

Countries

Japan

Contacts

Public ContactYuki Sakai

Graduate School of Medical Science, Kyoto Prefectural University of Medicine Department of Psychiatry

yuki1209@koto.kpu-m.ac.jp075-251-5612

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026